Development of Biomaterial-based Delivery Systems for Parkinson’s disease - an Integrated Pan-European Approach


BrainMatTrain focuses on a comprehensive understanding of Parkinson’s disease, from basics to translation, fully supported by eight full partners (four research institutions, two hospitals, two SMEs) and one partner organisation (SME specialist in device design). This European Training Network will educate and train 15 Early Stage Researchers (ESRs) in functionalised biomaterials, materials science, functionalisation strategies, molecular biology, stem cell biology, in vitro model systems, in vivo neuroimaging, preclinical models and prototype design. Recruited ESRs will receive compulsory discipline-specific, generic and complementary transferable skills training.

BrainMatTrain will develop multi-modal collagen reservoir scaffolds incorporating moieties targeting the neuroinflammatory and neuroprotective phases of the underlying pathology of Parkinson’s disease. The researchers will undertake cross-disciplinary and intersectorial research projects, which when married together will deliver a novel, biomaterial-based, therapeutic device for the treatment of Parkinson’s disease. The research training programme is designed to ensure high-calibre graduates, best placed to secure employment in the private or public sector. Fellows will experience both private and public sector research and development environments through a considered secondment plan.

The BrainMatTrain project is funded by the European Union Horizon 2020 Programme (H2020-MSCA-ITN-2015) under the Marie Skłodowska-Curie Initial Training Network and Grant Agreement No. 676408.

EU logo  ‌ ‌